BREVIBLOC 10mg / ml infusion solution medication leaflet

C07AB09 esmolol • Cardiovascular system | Beta blocking agents | Beta blocking agents, selective

Esmololum is a medication used for the treatment of supraventricular tachycardia and acute hypertension, particularly in emergency situations. It is a cardioselective beta-blocker with rapid action, reducing heart rate and blood pressure.

The medication is administered via intravenous infusion under medical supervision, and the dosage is adjusted based on the patient's response.

Common side effects include hypotension, bradycardia, dizziness, and nausea. In rare cases, more severe adverse effects such as heart failure or bronchospasm may occur.

Esmololum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about BREVIBLOC 10mg / ml

Substance: esmolol

Date of last drug list: 01-06-2025

Commercial code: W70513001

Concentration: 10mg / ml

Pharmaceutical form: infusion solution

Quantity: 1

Product type: generic

Price: 707.62 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BAXTER S.A. - BELGIA

Holder: FARMACEUTICA REMEDIA DISTRIBUTION&LOGISTICS S.R.L. - ROMANIA

Number: 955/2024/01

Concentrations available for esmolol

100mg/10ml, 10mg/ml